Mettler-Toledo International (NYSE:MTD) Insider Gerry Keller Sells 435 Shares of Stock

Mettler-Toledo International, Inc. (NYSE:MTD) insider Gerry Keller sold 435 shares of the business’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $1,734.05, for a total transaction of $754,311.75. Following the transaction, the insider owned 259 shares of the company’s stock, valued at approximately $449,118.95. The trade was a 62.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,749.74 on Wednesday. The firm has a market capitalization of $34.80 billion, a PE ratio of 37.91, a price-to-earnings-growth ratio of 3.52 and a beta of 1.16. The business’s fifty day moving average price is $1,538.82 and its 200 day moving average price is $1,349.09. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,806.58.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $12.13 by $0.44. The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.07 billion. Mettler-Toledo International had a return on equity of 15,012.71% and a net margin of 22.25%. Mettler-Toledo International’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $11.15 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 47.83 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently made changes to their positions in MTD. XXEC Inc. acquired a new position in Mettler-Toledo International during the second quarter worth about $77,044,000. BlackRock Inc. purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $2,404,713,000. Bank of New York Mellon Corp acquired a new position in shares of Mettler-Toledo International in the second quarter valued at approximately $762,553,000. Wellington Management Group LLP boosted its position in Mettler-Toledo International by 908.6% during the second quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock worth $586,459,000 after acquiring an additional 413,547 shares during the last quarter. Finally, Aberdeen Group plc boosted its position in Mettler-Toledo International by 1,214.7% during the third quarter. Aberdeen Group plc now owns 245,978 shares of the medical instruments supplier’s stock worth $371,660,000 after acquiring an additional 227,268 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

MTD has been the subject of several recent analyst reports. Barclays boosted their target price on Mettler-Toledo International from $1,700.00 to $1,900.00 and gave the stock an “overweight” rating in a research note on Monday. Weiss Ratings upgraded shares of Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. Morgan Stanley boosted their price objective on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Finally, Rothschild & Co Redburn began coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective for the company. Six research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $1,595.77.

More Mettler-Toledo International News

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Barclays raised its target from $1,700 to $1,900 and maintained an overweight rating; Stifel lifted its target from $1,600 to $1,900 and assigned a buy rating. Both targets imply further upside from the reference share price of $1,749.74. Barclays price target article Stifel price target article
• Neutral Sentiment: Robert W. Baird raised its target from $1,608 to $1,815 but kept a neutral rating. JPMorgan also retained a neutral rating despite lifting its target from $1,550 to $1,725. Goldman Sachs raised its target from $1,510 to $1,640, still below the reference share price—signaling that analyst views remain divided. Baird price target article Goldman Sachs price target article
• Negative Sentiment: Insider Gerry Keller sold 435 shares for about $754,000, reducing his direct holding by 62.68% to 259 shares. Insider sales can weigh on sentiment, though the filing alone does not indicate the reason for the transaction. SEC insider transaction filing

Mettler-Toledo International Company Profile

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.